Technologies

Vascular Access Graft

InnAVasc’s novel graft modification technology is designed to create one contiguous flow lumen without transition points. The key innovative features of this technology include: 

  1. Self-sealing needle stick zone intended to allow for durable cannulation and immediate use for hemodialysis post implantation
  2. Potential for reduction or elimination in dialysis catheter use
  3. Directed cannulation allows for predictable, reliable access
  4. Designed with features to prevent back wall puncture injury and side wall laceration injuries and thereby improve safety
  5. Designed for ease of use regardless of cannulation experience, including patients, family members, and new dialysis technicians
 
InnAVasc Medical, Inc. is a medical device company founded by Duke University surgeons and scientists, which designs and develops products for vascular access for hemodialysis. The Company's first technology is an arteriovenous graft (AVG) modification that incorporates two multilayer cannulation chambers, with low bleed technology, that are resistant to posterior and sidewall needle penetration and injury: the Bullet Proof Vascular Access Graft.
The InnAVasc AV Graft is for investigational use only. The device has not been cleared to market by the U.S. FDA. 

The InnAVasc AV Graft is for investigational use only. The device has not been cleared to market by the U.S. FDA. 

 

CAUTION - Investigational device, exclusively for clinical investigation.

Limited by United States law to investigational use.